List of Tables
Table 1. Global Nuclear Medicine Cyclotron Systems Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Nuclear Medicine Cyclotron Systems Market Value by Disease (US$ Million), 2025 vs 2032
Table 3. Global Nuclear Medicine Cyclotron Systems Market Value by Usage Scenario (US$ Million), 2025 vs 2032
Table 4. Global Nuclear Medicine Cyclotron Systems Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Nuclear Medicine Cyclotron Systems Market Competitive Situation by Manufacturers in 2025
Table 6. Global Nuclear Medicine Cyclotron Systems Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Nuclear Medicine Cyclotron Systems Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Nuclear Medicine Cyclotron Systems Average Price (M US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Nuclear Medicine Cyclotron Systems, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Product Types and Applications
Table 14. Global Key Manufacturers of Nuclear Medicine Cyclotron Systems, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Nuclear Medicine Cyclotron Systems Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nuclear Medicine Cyclotron Systems Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Nuclear Medicine Cyclotron Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Nuclear Medicine Cyclotron Systems Sales by Region (Units), 2021–2026
Table 20. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2021–2026)
Table 21. Global Nuclear Medicine Cyclotron Systems Sales by Region (Units), 2027–2032
Table 22. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2027–2032)
Table 23. Global Nuclear Medicine Cyclotron Systems Revenue by Region (US$ Million), 2021–2026
Table 24. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2021–2026)
Table 25. Global Nuclear Medicine Cyclotron Systems Revenue by Region (US$ Million), 2027–2032
Table 26. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2027–2032)
Table 27. North America Nuclear Medicine Cyclotron Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2021–2026
Table 29. North America Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2027–2032
Table 30. North America Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2021–2026
Table 31. North America Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Nuclear Medicine Cyclotron Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2021–2026
Table 34. Europe Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2027–2032
Table 35. Europe Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Nuclear Medicine Cyclotron Systems Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Nuclear Medicine Cyclotron Systems Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Nuclear Medicine Cyclotron Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2021–2026
Table 44. Latin America Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2027–2032
Table 45. Latin America Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Nuclear Medicine Cyclotron Systems Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue by Country (US$ Million), 2027–2032
Table 52. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Type (2021–2026)
Table 53. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Type (2027–2032)
Table 54. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Type (2021–2026)
Table 55. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Type (2027–2032)
Table 56. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Type (2021–2026)
Table 59. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Type (2027–2032)
Table 60. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Type (2021–2026)
Table 61. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Type (2027–2032)
Table 62. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Application (2021–2026)
Table 63. Global Nuclear Medicine Cyclotron Systems Sales (Units) by Application (2027–2032)
Table 64. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2021–2026)
Table 65. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2027–2032)
Table 66. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Nuclear Medicine Cyclotron Systems Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application (2021–2026)
Table 69. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application (2027–2032)
Table 70. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Application (2021–2026)
Table 71. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Application (2027–2032)
Table 72. GE Healthcare Company Information
Table 73. GE Healthcare Description and Business Overview
Table 74. GE Healthcare Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit), and Gross Margin (2021–2026)
Table 75. GE Healthcare Nuclear Medicine Cyclotron Systems Product
Table 76. GE Healthcare Recent Developments/Updates
Table 77. IBA Company Information
Table 78. IBA Description and Business Overview
Table 79. IBA Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit), and Gross Margin (2021–2026)
Table 80. IBA Nuclear Medicine Cyclotron Systems Product
Table 81. IBA Recent Developments/Updates
Table 82. Best Cyclotron Systems Company Information
Table 83. Best Cyclotron Systems Description and Business Overview
Table 84. Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit), and Gross Margin (2021–2026)
Table 85. Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Product
Table 86. Best Cyclotron Systems Recent Developments/Updates
Table 87. Advanced Cyclotron Systems (ACSI) Company Information
Table 88. Advanced Cyclotron Systems (ACSI) Description and Business Overview
Table 89. Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit), and Gross Margin (2021–2026)
Table 90. Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Product
Table 91. Advanced Cyclotron Systems (ACSI) Recent Developments/Updates
Table 92. Sumitomo Heavy Industries Company Information
Table 93. Sumitomo Heavy Industries Description and Business Overview
Table 94. Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit), and Gross Margin (2021–2026)
Table 95. Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Product
Table 96. Sumitomo Heavy Industries Recent Developments/Updates
Table 97. Longevous Beamtech Company Information
Table 98. Longevous Beamtech Description and Business Overview
Table 99. Longevous Beamtech Nuclear Medicine Cyclotron Systems Sales (Units), Revenue (US$ Million), Price (M US$/Unit), and Gross Margin (2021–2026)
Table 100. Longevous Beamtech Nuclear Medicine Cyclotron Systems Product
Table 101. Longevous Beamtech Recent Developments/Updates
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Nuclear Medicine Cyclotron Systems Distributors List
Table 105. Nuclear Medicine Cyclotron Systems Customers List
Table 106. Nuclear Medicine Cyclotron Systems Market Trends
Table 107. Nuclear Medicine Cyclotron Systems Market Drivers
Table 108. Nuclear Medicine Cyclotron Systems Market Challenges
Table 109. Nuclear Medicine Cyclotron Systems Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nuclear Medicine Cyclotron Systems
Figure 2. Global Nuclear Medicine Cyclotron Systems Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Nuclear Medicine Cyclotron Systems Market Share by Type: 2025 & 2032
Figure 4. Cyclotron Less than 12 MeV Product Picture
Figure 5. Cyclotron 13-18 MeV Product Picture
Figure 6. Cyclotron 19-24 MeV Product Picture
Figure 7. Cyclotron More than 24 MeV Product Picture
Figure 8. Global Nuclear Medicine Cyclotron Systems Market Value by Disease (US$ Million), 2021–2032
Figure 9. Global Nuclear Medicine Cyclotron Systems Market Share by Disease: 2025 vs 2032
Figure 10. Cancer Treatment Product Picture
Figure 11. Cardiology Product Picture
Figure 12. Neurology Product Picture
Figure 13. Infectious Diseases Product Picture
Figure 14. Others Product Picture
Figure 15. Global Nuclear Medicine Cyclotron Systems Market Value by Usage Scenario (US$ Million), 2021–2032
Figure 16. Global Nuclear Medicine Cyclotron Systems Market Share by Usage Scenario: 2025 vs 2032
Figure 17. Diagnostic Imaging Product Picture
Figure 18. Therapeutic Isotope Production Product Picture
Figure 19. Global Nuclear Medicine Cyclotron Systems Market Value by Application (US$ Million), 2021–2032
Figure 20. Global Nuclear Medicine Cyclotron Systems Market Share by Application: 2025 & 2032
Figure 21. Hospital
Figure 22. Pharmaceutical Industry
Figure 23. Research & Academics
Figure 24. Global Nuclear Medicine Cyclotron Systems Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Nuclear Medicine Cyclotron Systems Market Size (US$ Million), 2021–2032
Figure 26. Global Nuclear Medicine Cyclotron Systems Sales (Units), 2021–2032
Figure 27. Global Nuclear Medicine Cyclotron Systems Average Price (M US$/Unit), 2021–2032
Figure 28. Nuclear Medicine Cyclotron Systems Report Years Considered
Figure 29. Nuclear Medicine Cyclotron Systems Sales Share by Manufacturers in 2025
Figure 30. Global Nuclear Medicine Cyclotron Systems Revenue Share by Manufacturers in 2025
Figure 31. Top 5 and Top 10 Global Nuclear Medicine Cyclotron Systems Players: Market Share by Revenue in Nuclear Medicine Cyclotron Systems in 2025
Figure 32. Nuclear Medicine Cyclotron Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 33. Global Nuclear Medicine Cyclotron Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 34. North America Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2021–2032)
Figure 35. North America Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2021–2032)
Figure 36. United States Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Canada Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Europe Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2021–2032)
Figure 39. Europe Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2021–2032)
Figure 40. Germany Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. France Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. U.K. Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Italy Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Russia Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Asia Pacific Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2021–2032)
Figure 46. Asia Pacific Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2021–2032)
Figure 47. China Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Japan Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. South Korea Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. India Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Australia Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Latin America Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2021–2032)
Figure 53. Latin America Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2021–2032)
Figure 54. Mexico Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Brazil Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Argentina Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Middle East and Africa Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2021–2032)
Figure 58. Middle East and Africa Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2021–2032)
Figure 59. Turkey Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 60. Saudi Arabia Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 61. U.A.E Nuclear Medicine Cyclotron Systems Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Global Sales Market Share of Nuclear Medicine Cyclotron Systems by Type (2021–2032)
Figure 63. Global Revenue Market Share of Nuclear Medicine Cyclotron Systems by Type (2021–2032)
Figure 64. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Type (2021–2032)
Figure 65. Global Sales Market Share of Nuclear Medicine Cyclotron Systems by Application (2021–2032)
Figure 66. Global Revenue Market Share of Nuclear Medicine Cyclotron Systems by Application (2021–2032)
Figure 67. Global Nuclear Medicine Cyclotron Systems Price (M US$/Unit) by Application (2021–2032)
Figure 68. Nuclear Medicine Cyclotron Systems Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
